Article
ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia.
Scientific reports - 20 May 2020
Hayun Michal, Zaatra Maria, Itzkovich Chen, Sahar Dvora, Rosenberg Dina, Filatova Margarita, Ringelstein-Harlev Shimrit, Baris Hagit, Moustafa-Hawash Nivin, Louria-Hayon Igal, Ofran Yishai
Abstract excerpt
Selection of resistant clones following intensive chemotherapy is a common obstacle for cure in many cancers, particularly in acute myeloid leukemia (AML). In AML, clone-specific sensitivity to chemotherapy varies even within the same patient. Multiple mutations and genetic aberrations are associated with clones surviving chemotherapy. The current study explored the role of activated signaling pathways in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
